|
PF-39890 |
NICOTINELL FRUTA 2 mg Masticables blandos (goma de mascar) |
2012-11-28 |
|
Novartis Consumer Health S.A. |
Suiza
|
Novartis Farmacéutica, Sociedad Anónima (América Central) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-39891 |
NICOTINELL MENTA 2 mg Masticables blandos (goma de mascar) |
2012-11-28 |
|
Novartis Consumer Health S.A. |
Suiza
|
Novartis Farmacéutica, Sociedad Anónima (América Central) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-34702 |
HYAL-SYSTEM 20 mg/1.1 mL Solucion Inyectable |
2010-01-18 |
|
Merz Pharmaceuticals GmbH |
Alemania
|
Amicelco |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PFD-50804 |
OXIMUM Polvo para solución oral |
2019-11-04 |
|
Drogueria e Importaciones La Californiana, S.A. |
Italia
|
Corp GLC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PFD-59544 |
SIFLAX Granulado para solución oral |
2026-06-09 |
|
Mefasa |
Italia
|
Mefasa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-36403 |
MONILAC 67.0 g/100 mL Jarabe |
2025-07-20 |
|
Pharland, S.A. |
República de Corea
|
Droguería Landívar |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-51788 |
BORTEZOMIB Flagship 3.5 mg Polvo liofilizado para uso parenteral |
2025-08-26 |
|
Flagship Biotech International |
India
|
Locress |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-51805 |
TEICOPLANINA Flagship 400 mg Polvo liofilizado para uso parenteral |
2026-07-15 |
|
Flagship Biotech International |
India
|
Locress |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-55525 |
LIDOCAINA Flagship 1 % Solución Inyectable |
2023-07-24 |
|
Flagship Biotech International |
India
|
BJM Pharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-55408 |
CISPLATINO Flagship 50 mg Solución Inyectable |
2023-06-22 |
|
Flagship Biotech International |
India
|
Futura |
Qadira |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|